Fig. 1

Therapeutic effect of immunotherapy with the LM∆E6E7 and LI∆E6E7 combination on subcutaneous TC-1 cell tumor mouse model. A Subcutaneous tumors of tumor-bearing mice taken at 1 week after completion of immunotherapy (n = 8). B The volume of subcutaneous tumors at 1 week after completion of immunotherapy (n = 8). C Survival curves in different mice groups, including cure rate and median survival time (n = 10)